BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 741319)

  • 1. Fatal hepatic necrosis in association with hycanthone.
    Hatchuel W
    S Afr Med J; 1978 Nov; 54(20):808. PubMed ID: 741319
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of schistosomiasis mansoni in Murang'a District, Kenya: a double blind controlled trial of three hycanthone regimens and oxamniquine.
    Rees PH; Bowry HN; Roberts JM; Thuku JJ
    Am J Trop Med Hyg; 1975 Sep; 24(5):823-6. PubMed ID: 1190368
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of oxamniquine in treatment of S. mansoni in a closed community in Egypt and the concomitant administration of both metrifonate and oxamniquine in mixed infections.
    Saif M; Gaber A; Hassanein YS; Khameis S
    J Egypt Med Assoc; 1978; 61(5-6):427-31. PubMed ID: 400362
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of oral therapy of mansonial schistosomiasis in the Sudan using single and multiple doses of hycanthone and oxamniquine drugs.
    Magzoub M; Adam SE
    J Pharmacol Exp Ther; 1978 Aug; 206(2):382-7. PubMed ID: 682120
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental chemotherapy of Schistosoma curassoni in mice.
    Vercruysse J; Southgate VR; Rollinson D; Hilderson H
    Parasitol Res; 1989; 75(7):559-62. PubMed ID: 2771923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of Schistosoma mansoni to schistosomicidal agents.
    de Souza Dias LC; de Jesus Pedro R; Deberaldini ER
    Trans R Soc Trop Med Hyg; 1982; 76(5):652-9. PubMed ID: 7179419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni.
    Haese WH; Bueding E
    J Pharmacol Exp Ther; 1976 Jun; 197(3):703-13. PubMed ID: 180276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations of the treatment of mansoni schistosomiasis with oxamniquine: efficacy in children and in persistent salmonellosis; resistance of a strain of Schistosoma mansoni; hepatic toxicity and neurological side effects.
    Pedro Rde J; de Souza Dias LC; Amato Neto V; de Carvalho SA
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):32-6, 148-52. PubMed ID: 7455507
    [No Abstract]   [Full Text] [Related]  

  • 9. Observations on the treatment of mansoni schistosomiasis with oxamniquine.
    Pedro RD; Dias LC; Amato Neto V; De Carvalho SA
    Rev Bras Pesqui Med Biol; 1979 Jun; 12(2-3):207-11. PubMed ID: 515473
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxamniquine in the treatment of various schistosome infections in South Africa.
    Pitchford RJ; Lewis M
    S Afr Med J; 1978 Apr; 53(17):677-80. PubMed ID: 354047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy of mansoni schistosomiasis].
    Zeitune JM; Ramos SR; Sugmyama LC; Côrte AA
    Arq Gastroenterol; 1980; 17(2):88-95. PubMed ID: 7213141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal hepatic necrosis in association with the use of hycanthone.
    Dennis EW
    S Afr Med J; 1978 Jul; 54(4):137-8. PubMed ID: 694710
    [No Abstract]   [Full Text] [Related]  

  • 13. [Resistance to hycanthone and oxamniquine in patients with a clinical hepato-intestinal form of schistosomiasis].
    Guimarães RX; Tchakerian A; Dias LC; de Almeida FM; Vilela MP; Cabeca M; Takeda AK
    AMB Rev Assoc Med Bras; 1979 Feb; 25(2):48-50. PubMed ID: 314642
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum enzymatic changes in patients with schistosomiasis treated with oxamniquine or hycanthone. Comparative study.
    Saéz-Alquézar A; Ohtsuki N; Sette Júnior H; Magnanelli AC; Raia S; da Silva LC
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):105-10, 225-31. PubMed ID: 7455503
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical development of oxamniquine in Egypt.
    Saif M; Gaber A
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):18-27, 134-43. PubMed ID: 7455504
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fatal hepatic necrosis after administration of hycanthone].
    Gigase PL; Mortelmans J; Van Marck EA
    Ann Soc Belg Med Trop; 1979; 59(4):431-4. PubMed ID: 543740
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular basis for hycanthone drug action in schistosome parasites.
    Guzman M; Rugel A; Tarpley RS; Cao X; McHardy SF; LoVerde PT; Taylor AB
    Mol Biochem Parasitol; 2020 Mar; 236():111257. PubMed ID: 32027942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curative chemotherapy and resistance to reinfection in murine schistosomiasis.
    Andrade ZA; Azevedo de Brito P
    Am J Trop Med Hyg; 1982 Jan; 31(1):116-21. PubMed ID: 7058973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the clinical pharmacology of hycanthone.
    Dennis EW; Kobus W
    Egypt J Bilharz; 1974; 1(1):35-53. PubMed ID: 4619885
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of chemotherapy on experimental pulmonary schistosomiasis.
    de Almeida MA; Andrade ZA
    Am J Trop Med Hyg; 1983 Sep; 32(5):1049-54. PubMed ID: 6625060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.